Accessibility Menu

Omnicell(FRA) OC9

Market Cap€1.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€30.00
+5.63%
+1.60Today

Omnicell Financials at a Glance

Market Cap

€1.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€1.07K

Net Income (TTM)

€33.53

EPS (TTM)

€0.73

P/E Ratio

39.14

Dividend

€0.00

Beta (Volatility)

0.04 (Low)

Price

€30.00

Volume

0

Open

€28.00

Previous Close

€30.00

Daily Range

€28.00 - €30.00

52-Week Range

€25.20 - €43.80

Estimated Earnings Date

N/A

OC9 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Omnicell

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.

Industry

Healthcare Equipment and Supplies

Employees

3,580

CEO

Randall A. Lipps

OC9 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

3.04%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

2.55%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€1.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

45.61M

Volume

0

Avg. Volume

0

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Omnicell Performance Analysis

Omnicell annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,233,091,02828.8%
20232023-12-31EUR 1,061,044,718-14.0%
20242024-12-31EUR 1,028,240,274-3.1%
20252025-12-31EUR 1,049,856,5912.1%
Omnicell annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.12-91.5%
20232023-12-31EUR -0.42N/A
20242024-12-31EUR 0.25N/A
20252025-12-31EUR 0.04-84.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€268.52

+1.0%

Gross Profit

€131.53

+1.2%

Gross Margin

48.98%

+1.1%

Market Cap

€1.30BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.45

N/A

Employees

3,580

N/A

Net Income

€20.89

+4.2%

EBITDA

€51.23

+2.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€457.23

-34.2%

Total Debt

€174.93

+0.5%

Accounts Receivable

€198.59

+1.0%

Inventory

€84.60

+0.9%

Long Term Debt

€164.88

+1.0%

Short Term Debt

€10.05

+0.1%

Return on Assets

1.88%

+1.8%

Return on Invested Capital

1.29%

+0.7%

Free Cash Flow

€51.29

+1.9%

Operating Cash Flow

€59.04

+1.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About OC9

What is the current price of Omnicell?

Omnicell is trading at €30.00 per share.

What is the 52-week range for Omnicell?

Over the past 52 weeks, Omnicell has traded between €25.20 and €43.80.

How much debt does Omnicell have?

As of the most recent reporting period, Omnicell reported total debt of €174.93M.

How much cash does Omnicell have on hand?

Omnicell reported €282.30M in cash and cash equivalents in its most recent financial results.

What is Omnicell’s dividend yield?

Omnicell does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.